Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Balwinder Singh
JCP
Letter to the Editor
BMI and Remission in Depressed Patients Receiving IV Ketamine
Few studies have evaluated optimal dosing of intravenous (IV) ketamine for treatment-resistant depression (TRD). This report analyzes data from previous studies of IV ketamine to assess the association between...
PCC
Review Article
Exercise, Yoga, and Tai Chi for Depression
Exercise, yoga, and tai chi are commonly used complementary approaches for health and wellness. This review aims to synthesize the evidence for exercise, yoga, and tai chi in the...
PCC
Article
Efficacy of Prazosin in PTSD
Prazosin is an emerging treatment modality for the debilitating symptoms of PTSD. But, while the evidence of its effectiveness and efficacy is promising, it is not definitive. The authors...
PCC
Meta-Analysis
Adjunctive Aripiprazole for MDD
Given the scarcity of data, the authors of this review systematically synthesized the literature to determine the long-term efficacy and safety of aripiprazole as a maintenance augmenting agent for...
JCP
ASCP Corner
Thyroid Hormone Use in Mood Disorders
This ASCP Corner article reviews the potential benefits and harms of thyroid hormone therapy in the management of unipolar and bipolar depression.
JCP
Original Research
Ketamine vs Esketamine for TRD
Are ketamine and esketamine equally efficacious? This observational study compares the efficacy of subanesthetic intravenous ketamine with that of intranasal esketamine for treatment-resistant depression in a real-world clinical setting.
JCP
ASCP Corner
When and How to Use Lithium Augmentation for MDD
With its antisuicidal effect and low cost, lithium can be an effective alternative to other MDD augmentation strategies when antidepressants are not enough.